Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC
Recruiting · NCT04324164 · Observational (researchers observe without assigning treatment) · Lead sponsor: Hunan Province Tumor Hospital
View the official record on ClinicalTrials.gov →Interventions studied
EGFR-TKIThird-generation EGFR-TKI
What this trial is about
This study aims to explore Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced Non-small Cell Lung Cancer in China
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- 18，Advanced Non-squamous Non-small Cell Lung Cancer Confirmed by Histopathology
- Uncommon EGFR Mutant Advanced NSCLC
Exclusion criteria
- Patients with contraindication of chemotherapy
- Pregnant or breast feeding women
Where it is running
1 location listed.
- Yongchang Zhang - Changsha, Hunan, China